Page 34 - Layout 1

UTHSCSA
DEAN’S MESSAGE

Continued from page 33 Every study, trial and experiment has many people behind the
scenes working to coordinate the many different pieces that
9 in patients with high blood potassium. Up to 98 percent of pa- come together to conduct and complete these programs. Most
tients saw a return to normal potassium levels in the first month. of the names do not appear as authors, but they are significant
Non-absorbed zirconium silicate, ZS-9, is designed to preferen- contributors all the same. My congratulations goes out to all the
tially trap potassium ions in order to lower and maintain control outstanding faculty and their teams for the great work repre-
of serum potassium levels. The articles appeared in the January sented here.
15, 2015 NEJM and December 2014 JAMA. ZS-9 was cleared
by the FDA for kidney patients in October 2015.

Refer a Patient or Partner to the All the best,
School of Medicine Francisco González-Scarano
Dean, School of Medicine Exec-
We offer the most clinical trials in the region (Phase 1, 2 and utive Vice President for Medical
3) for many different conditions and diseases. If you’re interested Affairs University of Texas
in referring a patient, please visit our clinical trial website Health Science Center San An-
http://vpr.uthscsa.edu/findastudy or our Phase 1 cancer trials at tonio John P. Howe, III, MD,
the Cancer Therapy & Research Center www.CTRC.net. Distinguished Chair in Health
Policy Professor of Neurology.
We also have a unique program for private physicians who wish
to be involved in clinical research. Called the “Practice-Based Re-
search Network” (PBRN), you can start your own studies or join
others already involved in research. Contact our PBRN office at
(210) 562-5652.

34 San Antonio Medicine • May 2016